Given this context, it is plausible that obesity‐induced metabolic reprogramming may alter YAP glycosylation patterns, which could, in turn, affect YAP ubiquitylation by modulating interactions with the deubiquitinase EIF3H. Here, EIF3H is linked to obesity disorder.